Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Azacitidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 344 Myelodysplastic Syndromes 148 Leukemia, Myelomonocytic, Chronic 68 Leukemia 60 Recurrence 28 Myeloproliferative Disorders 20 Neoplasms 19 Hematologic Neoplasms 17 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Carcinoma, Non-Small-Cell Lung 16 Multiple Myeloma 14 Anemia, Refractory, with Excess of Blasts 14 Lymphoma, T-Cell, Peripheral 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Neoplasm, Residual 12 Lymphoma, Large B-Cell, Diffuse 12 Leukemia, Lymphocytic, Chronic, B-Cell 11 Leukemia, Biphenotypic, Acute 11 Primary Myelofibrosis 10 Leukemia, Monocytic, Acute 9 Hodgkin Disease 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Myelodysplastic-Myeloproliferative Diseases 8 Leukemia, Myelomonocytic, Acute 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia, Erythroblastic, Acute 8 Breast Neoplasms 8 Neoplasm Metastasis 7 Lymphoma, Follicular 7

Interventions

Temozolomide 143 Bevacizumab 63 Radiotherapy 60 Magnetic Resonance Spectroscopy 58 Irinotecan 27 Carboplatin 23 Surgical Procedures, Operative 22 Radiation 19 Carmustine 18 Aminolevulinic Acid 18 Specimen Handling 17 Nivolumab 16 Blood Specimen Collection 16 Lomustine 15 Biopsy 15 pembrolizumab 13 Radiotherapy, Intensity-Modulated 12 Cyclophosphamide 12 trametinib 11 Topotecan 11 Radiosurgery 11 Erlotinib Hydrochloride 11 fluorodopa F 18 10 X-Rays 10 IL13-PE38 9 Everolimus 9 ribociclib 8 dabrafenib 8 Surveys and Questionnaires 8 Magnetic Resonance Imaging 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03666559 2024-02-29

AGIR

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡